doi: 10.1161/01.HYP.0000060141.52886.ab
(Hypertension. 2003;41:860.)
© 2003 American Heart Association, Inc.
Awards |
18th Annual Aventis Pharma Hypertension Research Clinical Fellowship Program Award
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
The purpose of this program and research award is to stimulate physicians-in-training to pursue a career in clinical research in hypertension. The research fellow must be conducting work in which he or she is the major senior investigator in any area of the researcher’s choice, including clinical or laboratory aspects of the hypertensive diseases. The fellow’s work would be supervised by the director of the research training program (the mentor), but the conduct of the investigation is primarily by the research fellow. The winning presentation receives $3,000, and the fellow’s mentor receives $25,000 to support the clinical investigative training of a research fellow the following year. 
| |||||||||||
Dr Hector Dourron received his medical degree from the University of Buenos Aires School of Medicine, Buenos Aires, Argentina. He spent 1 year in the Department of Orthopedic Surgery at Emory University, Atlanta, Georgia. and subsequently received 4 years of general surgery training at State University of New York, Stony Brook, New York. Dr Dourron is currently a senior fellow in the Vascular Surgery Division at Henry Ford Hospital, Detroit, Michigan. He received this award for his work entitled "Adventitial gene transfer of NAD(P)H oxidase inhibitor suppresses increased superoxide following balloon angioplasty in the rat carotid artery." This work was performed under the supervision of Dr Patrick J. Pagano in the Hypertension and Vascular Research Division at the Henry Ford Hospital.
Previous Recipients
2001
Richard A. Birnbaum, MD
University of